ALID (Allied) Retained Earnings: $-50.37 Mil (As of Nov. 2024)


What is Allied Retained Earnings?

Allied ALID -99.80% Retained Earnings is $-50.37 Mil as of Nov. 2024.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Allied's retained earnings for the quarter that ended in Nov. 2024 was $-50.37 Mil.

Allied's quarterly retained earnings declined from May. 2024 ($-48.20 Mil) to Aug. 2024 ($-49.59 Mil) and declined from Aug. 2024 ($-49.59 Mil) to Nov. 2024 ($-50.37 Mil).

Allied's annual retained earnings declined from Aug. 2022 ($-34.93 Mil) to Aug. 2023 ($-45.61 Mil) and declined from Aug. 2023 ($-45.61 Mil) to Aug. 2024 ($-49.59 Mil).

Allied  (OTCPK:ALID) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Allied Retained Earnings Historical Data

* Premium members only.

The historical data trend for Allied's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allied Retained Earnings Chart

Allied Annual Data
Trend Mar18 Mar19 Aug20 Aug21 Aug22 Aug23 Aug24
Retained Earnings
Get a 7-Day Free Trial -7.91 -19.39 -34.93 -45.61 -49.59

Allied Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -46.45 -47.31 -48.20 -49.59 -50.37

Allied Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-50.37 Mil mean?
Allied (ALID) has a Retained Earnings of $-50.37 Mil as of Nov. 2024. Retained earnings is the amount of net income not issued to shareholders. View historical data on Allied and its competitors.
Is Allied's Retained Earnings too high?
Allied's current Retained Earnings is $-50.37 Mil.
How does Allied's Retained Earnings compare to CBDY and PLSH?
Allied's Retained Earnings of $-50.37 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Drug Manufacturers company?
A good Retained Earnings depends on the Drug Manufacturers industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Allied and its competitors. Allied's current Retained Earnings is $-50.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allied stock overvalued right now?
Allied (ALID) has a current Retained Earnings of $-50.37 Mil. The current Retained Earnings is $-50.37 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Allied (ALID), the current Retained Earnings is $-50.37 Mil as of Nov. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Allied Business Description

Address 460 Doyle Avenue, Suite 200, Kelowna, BC, CAN, V1Y OC2
Allied Corp is an international cannabis company with a mission to help people suffering from Post-Traumatic Stress Disorder (PTSD) by researching, creating, and producing targeted cannabinoid health solutions. The company uses an evidence-informed scientific approach to make this mission possible through cutting-edge pharmaceutical research and development, plant-based production, and the development of therapeutic products. The company operates in two segments, which include Allied and Allied Colombia. Its geographical segments consist of Colombia and Canada. The company's revenue is comprised of sales of cannabis products.